Pharmacological treatment of the benign prostatic syndrome (symptomatic BPH) using alpha1-adrenoceptor antagonists. Basic principles and clinical results;Medikamentöse therapie des benignen prostatasyndroms mit α 1-rezeptorblockern. Grundlagen und klinische ergebnisse

Urologe - Ausgabe A

Volumn 41, Issue 5, 2002, Pages 425-441

  Oelke, M ^a   Hofner K ^b   Berges, R R ^c   Jonas, U ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Evangelisches Krankenhaus Oberhausen   (Germany)

^c PAN Klinik am Neumarkt   (Germany)

Author keywords

Alpha1 adrenoceptor antagonists; Alpha1 blockers; BPH; Efficacy; Tolerability

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; FINASTERIDE; PLACEBO; PLANT EXTRACT; PYGEUM AFRICANUM EXTRACT; SABAL EXTRACT; TAMSULOSIN; TERAZOSIN; UROXATHRAL UNO;

ADRENERGIC SYSTEM; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICTURITION; MUSCLE HYPOTONIA; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; PHARMACODYNAMICS; PHARMACOKINETICS; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RETROGRADE EJACULATION; REVIEW; RHINITIS; SKIN MANIFESTATION; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA; URINE RETENTION; VERTIGO; XEROSTOMIA;

ADRENERGIC ALPHA-ANTAGONISTS; CLINICAL TRIALS; HUMANS; MALE; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ADRENERGIC, ALPHA-1; TREATMENT OUTCOME; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 0036933703     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-002-0236-9     Document Type: Review

References (0)